| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
123,171 |
102,976 |
$24.64M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
84,990 |
55,612 |
$1.45M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
26,167 |
17,685 |
$706K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
25,959 |
18,763 |
$427K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,777 |
5,128 |
$357K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,865 |
4,585 |
$355K |
| 59425 |
|
3,731 |
2,701 |
$309K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,170 |
2,733 |
$255K |
| 92551 |
|
20,183 |
13,629 |
$245K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,959 |
1,347 |
$174K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,986 |
2,757 |
$168K |
| 90686 |
|
13,924 |
9,148 |
$156K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,229 |
824 |
$94K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,348 |
853 |
$74K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,357 |
2,221 |
$60K |
| H1003 |
Prenatal care, at-risk enhanced service; education |
2,019 |
1,246 |
$55K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,031 |
7,203 |
$49K |
| 90648 |
|
4,116 |
2,839 |
$45K |
| G9920 |
Screening performed and negative |
1,084 |
1,083 |
$45K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
720 |
508 |
$41K |
| 90670 |
|
3,424 |
2,360 |
$41K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
454 |
334 |
$36K |
| 20553 |
|
1,048 |
643 |
$35K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
630 |
454 |
$34K |
| 90651 |
|
1,853 |
1,340 |
$30K |
| 90723 |
|
2,624 |
1,846 |
$29K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
1,179 |
710 |
$28K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,557 |
5,750 |
$26K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
481 |
331 |
$22K |
| 90746 |
|
426 |
334 |
$21K |
| 90688 |
|
1,155 |
1,154 |
$21K |
| 90715 |
|
1,177 |
814 |
$21K |
| 85018 |
|
13,464 |
8,843 |
$15K |
| 99173 |
|
2,249 |
2,246 |
$15K |
| 90734 |
|
1,154 |
779 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,868 |
1,062 |
$15K |
| 90633 |
|
1,294 |
851 |
$14K |
| 99188 |
|
1,112 |
705 |
$14K |
| 0071A |
|
195 |
101 |
$10K |
| 90681 |
|
933 |
663 |
$10K |
| 20610 |
|
280 |
178 |
$10K |
| 96158 |
|
420 |
275 |
$9K |
| 97803 |
|
377 |
287 |
$9K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,252 |
893 |
$9K |
| 81025 |
|
3,936 |
2,810 |
$8K |
| 99401 |
|
336 |
240 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
705 |
438 |
$6K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,175 |
762 |
$6K |
| 0072A |
|
106 |
54 |
$6K |
| 90674 |
|
297 |
297 |
$5K |
| 90677 |
|
657 |
474 |
$5K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
66 |
60 |
$5K |
| 90621 |
|
374 |
234 |
$4K |
| 99215 |
Prolong outpt/office vis |
86 |
68 |
$4K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
306 |
210 |
$4K |
| J3490 |
Unclassified drugs |
83 |
65 |
$4K |
| 90685 |
|
172 |
172 |
$3K |
| 96151 |
|
119 |
62 |
$3K |
| 90710 |
|
189 |
159 |
$3K |
| 90707 |
|
143 |
90 |
$3K |
| 90750 |
|
23 |
15 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
800 |
483 |
$2K |
| 92083 |
|
50 |
44 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,035 |
951 |
$2K |
| 97802 |
|
14 |
14 |
$2K |
| H2000 |
Comprehensive multidisciplinary evaluation |
12 |
12 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
324 |
246 |
$1K |
| 90620 |
|
77 |
76 |
$1K |
| 90716 |
|
144 |
91 |
$1K |
| 99381 |
|
64 |
59 |
$1K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
12 |
12 |
$974.75 |
| 90696 |
|
75 |
53 |
$954.00 |
| 90656 |
|
417 |
392 |
$881.43 |
| 0001A |
|
18 |
13 |
$855.00 |
| 81002 |
|
860 |
585 |
$783.00 |
| 99406 |
|
107 |
101 |
$741.75 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
32 |
26 |
$689.84 |
| 0002A |
|
16 |
15 |
$667.00 |
| 90700 |
|
55 |
38 |
$612.00 |
| 81003 |
|
214 |
210 |
$469.21 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
236 |
174 |
$311.24 |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
14 |
14 |
$235.48 |
| S9452 |
Nutrition classes, non-physician provider, per session |
13 |
13 |
$218.66 |
| 82962 |
|
68 |
39 |
$95.23 |
| 86580 |
|
14 |
14 |
$88.20 |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
70 |
65 |
$58.75 |
| 88720 |
|
15 |
13 |
$25.80 |
| 96161 |
|
3,367 |
3,363 |
$12.86 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
71 |
35 |
$1.40 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
198 |
183 |
$0.50 |
| Z1034 |
|
3,052 |
2,286 |
$0.00 |
| Z6410 |
|
1,510 |
845 |
$0.00 |
| Z6406 |
|
714 |
541 |
$0.00 |
| Z6204 |
|
413 |
318 |
$0.00 |
| Z1032 |
|
12 |
12 |
$0.00 |
| Z1038 |
|
14 |
13 |
$0.00 |
| G0010 |
Administration of hepatitis b vaccine |
16 |
16 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
32 |
32 |
$0.00 |
| Z6304 |
|
734 |
481 |
$0.00 |
| 99499 |
|
326 |
326 |
$0.00 |
| Z6400 |
|
234 |
233 |
$0.00 |
| 99442 |
|
15 |
14 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
28 |
28 |
$0.00 |